Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 10, Pages e003499
Publisher
BMJ
Online
2021-10-05
DOI
10.1136/jitc-2021-003499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
- (2021) Anders H. Kverneland et al. CYTOTHERAPY
- CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
- (2020) Christina Friese et al. Scientific Reports
- On the mechanism of anti-CD39 immune checkpoint therapy
- (2020) David Allard et al. Journal for ImmunoTherapy of Cancer
- In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes
- (2020) Morten Nielsen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response
- (2020) Michal J. Besser et al. MOLECULAR CARCINOGENESIS
- Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
- (2020) Anders Handrup Kverneland et al. Oncotarget
- CD39 identifies the CD4+ tumor-specific T cell population in human cancer
- (2020) Kim E Kortekaas et al. Cancer Immunology Research
- Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
- (2020) Joost H van den Berg et al. Journal for ImmunoTherapy of Cancer
- Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
- (2020) Sri Krishna et al. SCIENCE
- Correlate tumor mutation burden with immune signatures in human cancers
- (2019) Xiaosheng Wang et al. BMC IMMUNOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
- (2019) Linh T. Nguyen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
- (2019) Marie Christine Wulff Westergaard et al. BRITISH JOURNAL OF CANCER
- Trial watch: dietary interventions for cancer therapy
- (2019) Sarah Lévesque et al. OncoImmunology
- Nivolumab in metastatic adrenocortical carcinoma: results of a phase II trial
- (2019) Benedito A Carneiro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy
- (2019) Xiaojie Yu et al. mAbs
- Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs
- (2019) Jody E. Phelan et al. Genome Medicine
- Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic Melanoma
- (2019) DOUGLAS ZIPPEL et al. ANTICANCER RESEARCH
- Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
- (2019) U Dafni et al. ANNALS OF ONCOLOGY
- PD-1 immunotherapy for recurrent or metastatic HNSCC
- (2019) Robert L Ferris et al. LANCET
- Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
- (2019) Sharon Yunger et al. OncoImmunology
- Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients
- (2018) Ronny Ben-Avi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome
- (2018) Marie-Andrée Forget et al. CLINICAL CANCER RESEARCH
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
- (2018) John E. Mullinax et al. Frontiers in Oncology
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
- (2018) Vassilis Genoud et al. OncoImmunology
- Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study
- (2018) Magnus Pedersen et al. OncoImmunology
- A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
- (2018) Sanja Stevanovic et al. CLINICAL CANCER RESEARCH
- Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
- (2018) Frank Stephen Hodi et al. LANCET ONCOLOGY
- Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
- (2017) Jon Bjoern et al. Oncotarget
- 4-1BB–Enhanced Expansion of CD8 + TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8 + T Cells
- (2017) Michiko Harao et al. Cancer Immunology Research
- Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
- (2016) R. Andersen et al. CLINICAL CANCER RESEARCH
- Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
- (2016) MacLean Hall et al. Journal for ImmunoTherapy of Cancer
- Opposite Effects of mGluR1a and mGluR5 Activation on Nucleus Accumbens Medium Spiny Neuron Dendritic Spine Density
- (2016) Kellie S. Gross et al. PLoS One
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
- (2015) Rikke Andersen et al. Human Vaccines & Immunotherapeutics
- CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
- (2015) Prakash K. Gupta et al. PLoS Pathogens
- PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
- (2015) J. R. Webb et al. Cancer Immunology Research
- Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor
- (2014) Marco Donia et al. CYTOTHERAPY
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
- (2013) M. J. Besser et al. CLINICAL CANCER RESEARCH
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients
- (2012) L. G. Radvanyi et al. CLINICAL CANCER RESEARCH
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
- (2011) Niels Junker et al. CYTOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now